The Impact of Peroxiredoxin 3 on Molecular Testing, Diagnosis, and Prognosis in Human Pancreatic Ductal Adenocarcinoma - Kakehashi, Anna; Suzuki, Shugo; Nishidoi, Yusaku; Hagihara, Atsushi; Ikenaga, Hiroko; Shiota, Masayuki; Qiu, Guiyu; Noura, Ikue; Kuwae, Yuko; Vachiraarunwong, Arpamas; Fujioka, Masaki; Gi, Min; et al. (Cancers, 2025)
Keywords: Adenocarcinoma; Age; Biological products; Biomarkers; Blood levels; Cancer; CD44 antigen; Classification; Diagnosis; Enzymes; Ethylenediaminetetraacetic acid; Extracellular vesicles; Females; FOXO3 protein; Growth patterns; Hospitals; Males; Matrix protein; Medical colleges; Medical prognosis; Medical records; Metastases; mRNA; Oxidative stress; Pancreatic cancer; Peroxiredoxin; Prognosis; Protein expression; Proteins; Proteomics; Reactive oxygen species; Reagents; Review boards; RNA; Software; Tumors; California; United States; Massachusetts; Japan; Pennsylvania; Canada; United States--US; peroxiredoxin 3; PDAC; extracellular vesicles; oxidative stress resistance; biomarker; mitochondria